Introduction
The ABO blood group is the most important blood group system in transfusion and transplantation medicine. Its antigenic determinants are oligosaccharides located on glycoproteins and glycolipids expressed on erythrocytes and tissue cells and occur in various body fluids and secretions. Depending on an individual's ABO blood type, IgM antibodies directed against the missing A and/or B antigens are regularly present in serum; they constitute an immunological barrier against incompatible blood transfusion and organ transplantation. The ABO gene codes for the glycosyltransferases that transfer specific sugar residues to H substance, resulting in the formation of blood group A and B antigens. This gene maps to chromosome 9, position 9q34.1-q34.2. It consists of seven exons, ranging in size from 28 to 688 base pairs (bp), and six introns with 554 to 12982 bp (Fig. 1) . [1] [2] [3] The last two exons (6 and 7), which comprise 823 of 1062 bp of the transcribed mRNA, encode for the catalytic domain of ABO glycosyltransferases.
The six common ABO alleles in Caucasians are ABO*A101 (A 1 ), ABO*A201 (A 2 ), polymorphism but possesses non-synonymous mutations that may abolish the protein's enzyme activity by altering the nt sugar binding site.
Eighty-three ABO alleles discriminated at 52 polymorphic sites within the coding region of the ABO gene have been reported in the literature so far. [4] [5] [6] [7] [8] [9] [10] In most cases the investigators only analyzed exons 6 and 7. The number of described ABO alleles increases to 88 when also nt differences within intron 6 are considered. Studies of the nt sequence of intron 6 have shown to be crucial for elucidation of the origin of some novel haplotypes. 11-13 To our knowledge, there is no information available on sequence variation of the non-coding regions upstream from exon 6, and little data on mutations within the first 5 exons of the ABO gene and their relevance for the ABO phenotypes. 14 In the present study, we therefore examined the complete exon/intron sequences (except for the huge intron 1 comprising 12982 bp) and two regulatory regions of common and rare ABO alleles to evaluate the genetic diversity and diversification at the ABO locus. The genomic sequence data were first correlated with the associated ABO phenotypes, then utilized for lineage definition.
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ABO genotyping of exons 6 and 7
The ABO genotype of all blood samples was first determined by screening exons 6 and 7 using a polymerase chain reaction method with sequence-specific primers (PCR-SSP). 10 Twenty-five healthy blood donors with common ABO blood groups and genotypes ABO*A101/ABO*A101 (n = 3), ABO*A201/ABO*A201 (n = 2), ABO*A101/ABO*A201 (n = 2), ABO*B101/ABO*B101 (n = 2), ABO*A101/ABO*B101 (n =2), ABO*O01/ABO*O01 (n = 4), ABO*O02/ABO*O02 (n =3), ABO*O01/ABO*O02 (n = 4), and ABO*O02/ABO*O03 (n = 3) were thereby selected.
PCR amplification and sequencing

Strategy
Our aim was to analyze all genomic sequences (except intron 1) and two regulatory regions allele were not available) were investigated using a generic sequence strategy (templates for sequence analysis were generated by amplifying both ABO alleles simultaneously) to establish an intermediate database. Then, samples heterozygous for common or rare ABO alleles were sequenced, first by generic sequencing, then by haplotype-specific sequencing (templates for sequence analysis were prepared using allele-specific primers) of at least one of the two alleles to define the cis/trans linkage of the polymorphic sites. The design of the allele specific amplification primers was based on the growing intermediate sequence database.
Thus, each allele was sequenced from at least two independent PCR products. Most sequences were obtained by forward and reverse sequencing. All amplification and sequencing primers as well as primer pairs used for amplification are listed in tables 1 to 3. 
PCR amplification
The PCR reaction mixture (final volume: 20 µl) contained 200 ng genomic DNA, PCR buffer (5X buffer: 300 mM Tris-HCl, 75 mM ammonium sulfate, 12.5 mM MgCl 2 , pH 9.0), 200 µM of each dNTPs, 5.0 pmol of each amplification primer and 0.3 units Taq DNA polymerase (Platinum Taq, GIBCO BRL, Life Technologies Inc., Maryland, USA). PCR amplification was carried out in a GenAmp PCR system 9600 (Perkin Elmer, Norwalk, CT, USA). After an initial denaturation step at 94°C for 2 min, the samples were subjected to 30 cycles of amplification, consisting of 10 two-temperature cycles (94°C for 10 s and 65°C for 60 s) followed by 20 three-temperature cycles (94°C for 10 s, 61°C for 50 s, and 72°C for 30 s).
The amplification products were separated electrophoretically and visualized on a 2.5 % agarose gel prestained with ethidium bromide (0.2 µg/ml). If two fragments occurred in the enhancer CBF-NFY region, the amplification products were purified from agarose gel for direct sequencing using the QIAquick gel extraction kit (Quiagen GmbH, Hilden, Germany) according to the manufacturer's instructions.
Sequencing of PCR products
Sequencing was carried out by dye terminator cycle sequencing chemistry (DYEnamic ET terminators, Amersham Pharmacia Biotech, Cleveland, USA) as described previously. 5, 9 Briefly, the sequencing reactions were performed in a 20 µl sample volume using 4 µl of a dye terminator mix containing fluorescence-labeled ddNTPs, dNTPs, Thermo Sequenase II DNA polymerase, and 3 pmol biotinylated sequencing primer. This mixture was subjected to 25 three-temperature cycles (96°C for 10 s, 50°C for 5 s, and 60°C for 4 min). For purification, the biotinylated products were attached to streptavidin-coated paramagnetic beads (Dynal A.S, Oslo, Norway) according to the manufacturers' instructions. Samples were washed once with 60 µl of 70 % ethanol and air dried. The single-stranded sequencing
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Phylogenetic analysis
The intron sequences of the 110 ABO alleles examined in this study were phylogenetically analyzed. The sequences were aligned using CLUSTAL W software run on the graphic interface program BioEdit version 5.0.9. 16, 17 Phylogenetic trees showing the phylogenetic relationship between the alleles were constructed according to the neighbor-joining method using Treecon version 1.3b. 18, 19 The trees were unrooted to get a topology representing the relative genetic distances between the ABO alleles.
Classification and nomenclature of ABO alleles
The ABO alleles were named according to the unofficial nomenclature used in the Blood Group Antigen Gene Mutation Database (http://www.bioc.aecom.yu.edu/bgmut/abo.htm).
Results
A total of 24 different ABO alleles were analyzed in this study (Tables 4 and 5 Three new mutations within the nt sequence of exon 7 were identified in this study (Table 4) . frame shift that produces a stop codon after nt 165 and premature termination of translation after AA 55. This abnormal ABO*O allele has been described only once before. 4 We detected it in a German blood group O donor.
Sequence diversity of non-coding regions of the ABO gene
The non-coding regions of the ABO gene were found to contain 61 polymorphic sites, most of which were located in introns 4 and 6. These polymorphisms consisted of simple point mutations (40 transitions, 15 transversions), one 2 bp deletion, and five insertions of up to 13 bp ( Table 5 ). The nt sequences in the promoter region of all common and rare ABO alleles were identical. Allele-specific motifs were found in the enhancer CBF-NFY region, as was described previously. 5 All non-ABO*A101-and ABO*O03-like alleles exhibited a 344-bp fragment containing four 43-bp repetitive motifs. The ABO*O02-like alleles and 51 % of the ABO*O01-like alleles also displayed a 41G>C mutation in the first (5') 43-bp sequence. The ABO*A101-and ABO*O03-like alleles, on the other hand, had a 215-bp enhancer CFB-NFY fragment with only a single copy of the 43-bp sequence motif bearing a 41G>A substitution.
As can be seen in were best discriminated by analyzing introns 5 and 6, both of which contained highly conserved lineage-specific sequence motifs ( Figure 2 ). In introns 2 to 4, the ABO*B alleles clustered together with the ABO*A alleles, whereas in intron 6 they clustered with the ABO*O03 group.
Inter-and intra-lineage allelic diversity at the ABO locus
All sequence variations found in this study are summarized in (ABO*Ax08) and between nt 437 of intron 2 and nt 106 of exon 3 (ABO*O12), respectively.
The sequence pattern of the rare ABO*O alleles ABO*O39 and ABO*O40 were more complex. Each of these alleles exhibited two exon and/or intron nt sequence motifs upstream from intron 5 which were specific for ABO*A and ABO*O01 group alleles, respectively. In two very unusual ABO*O alleles, ABO*O21 and ABO*O41, both belonging to the ABO*A group, only singular polymorphisms were detected, including A transferase activity abolishing mutations in exon 6 (261delG) and exon 2 (88insG), respectively.
Discussion
In the present study, we investigated the entire genomic sequence (except for intron 1) and two regulatory regions of 110 common and variant ABO haplotypes to identify variations in the non-coding regions and polymorphisms in the coding region possibly responsible for common and variant ABO phenotypes. Only known nt polymorphisms were detected in the coding region outside exon 7. Twenty-one known and three new ABO alleles were thereby identified. Each new allele was characterized by the addition of a new single base substitution in exon 7. A 592C>T substitution found on an ABO*A201 background was associated with very weak A antigen expression (ABO*Aw07). This is the first time that a mutation relevant for ABO subgroup expression was detected between nts 548 and 641 of the coding sequence.
This finding suggests that changes in this region can also affect the sugar binding domain of ABO glycosyltransferase. However, the question of whether the new mutation acts alone or in combination with typical ABO*A201 polymorphisms to yield altered A antigen expression is still unanswered. The second non-synonymous new mutation (1037A>T) was located near the 3' end of the gene. The occurrence of this mutation in an ABO*B101-like allele was associated with a diminution of B antigen expression (ABO*Bw08). This was not surprising since an alteration of B antigen expression has already been described for a mutation at position 1036 in a variant ABO*B allele.
14 The third phenotypically relevant mutation was found in a genotype with ABO*O03-defining mutations (297A>G, 526C>G, 802G>A) in homozygosity.
While the mutation at position 802 is known to abolish the enzymatic activity of the ABO glycosyltransferase, the simultaneous presence of a new mutation at position 488 near the 5' end of exon 7 seemed to reactivate the A transferase activity. The resulting new ABO*A allele (ABO*Aw08) is the first reported ABO*O-like allele with an additional mutation that seems to be responsible for "reactivation" of A antigen expression. Although mutations in the 5' region of exon 7 were thought to be incapable of drastically altering enzymatic activity or specificity,
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These include variations in minisatellite repeats in the 5' untranslated region (UTR) and single-nt polymorphisms in intron 6 and the 3' UTR. 11 -13,20 The pattern of these variations was concordant with the major ABO alleles. Moreover, the discovery of ABO allele-specific haplotypes of intron 6 allowed for identification of break points of recombination events and localization of recombination hot spots around intron 6 and exon 7. Yamamoto, who phylogenetically analyzed the coding sequences of human and primate ABO alleles. 21 However, our intron data may carry more weight than the exon data because substitutions in introns are presumably less susceptible to selection pressure, so they may reflect the phylogeny of the alleles more reliably.
22
The frequency of replacement mutations (73 %) indicates the occurrence of positive selection for allelic diversity. Two mechanisms are considered to be responsible for genetic diversity and diversification at the ABO locus: point mutations and genetic recombination (cross-overs and gene conversion). 9 By extending the sequence analysis to the entire coding region and to 5 of the 6 introns of the ABO gene, we were able to confirm the important role of both mechanisms in generating the extensive sequence variations at the ABO locus. Whereas the For personal use only. on November 12, 2017. by guest www.bloodjournal.org From 
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